MedPath

Evaluation and Comparison of safety & Efficacy of four skin care formulations

Not Applicable
Registration Number
CTRI/2022/01/039692
Lead Sponsor
MERCK PERFORMANCE MATERIALS PVT LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Indian Asian female subjects

Healthy subjects no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup

Between 35 and 55 years of age.

Skin is healthy on the studied anatomic unit free of eczema, wounds, inflammatory scar

Subject having Crows feet wrinkle of grade 2 and above according to the Bazins atlas. using Page number 40 of Skin Ageing Atlas

Subject having visible dry skin.

Exclusion Criteria

Having started, changed or stopped a hormonal treatment in the past 3 months.

Having taken an oral retinoid-based treatment in the past 6 months

Having taken a local retinoid-based treatment on the studied areas in the previous month

Having had beauty treatment in the previous week

Having practiced water activities in the previous week.

Having consumed caffeine-based products, alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements

Having practiced intensive sports during the day prior to the T0 measurements

Having wounds, Scars, sunburns, tattoos and piercing on test site.

Having hair on test site.

Having applied another product than water on the studied areas in the morning of the T0 measurements

Having had an intensive UV exposition on the inner forearm prior to T0 measurements

Having used cosmetic product on the studied area during 24 hours prior to T0 measurements.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the safety and efficacy of a skin care formulation in terms of reduction of wrinklesTimepoint: T0, T28days, T56days
Secondary Outcome Measures
NameTimeMethod
To study the efficacy of all the test products in terms of reduction in density of dark spots & <br/ ><br>improvement in skin moisturization, skin firmness and skin brighteningTimepoint: T0, T28days, T56days
© Copyright 2025. All Rights Reserved by MedPath